Definition and Quantification of Six Immune- and Neuroregulatory Serum Proteins in Healthy and Demented Elderly

References

• Heneka MT , CarsonMJ, ElKhoury Jet al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol., 14(4), 388–405 (2015).
   PubMed Web of Science ®Google Scholar
• Perry VH , CunninghamC, HolmesC. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol., 7(2), 161–167 (2007).
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T . TGF-β pathway as a potential target in neurodegeneration and Alzheimers. Curr. Alzheimer Res., 3(3), 191–195 (2006).
   PubMedGoogle Scholar
• Wyss-Coray T , RogersJ. Inflammation in Alzheimer disease – a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med., 2(1), a006346 (2012).
   PubMed Web of Science ®Google Scholar
• Brosseron F , KrauthausenM, KummerM, HenekaMT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview. Mol. Neurobiol., 50(2), 534–544 (2014).
   PubMed Web of Science ®Google Scholar
• López-Bascón MA , Priego-CapoteF, Peralbo-MolinaA, Calderón-SantiagoM, LuqueDe Castro MD. Influence of the collection tube on metabolomic changes in serum and plasma. Talanta, 150, 681–689 (2016).
   PubMed Web of Science ®Google Scholar
• De Jager W , BourcierK, RijkersGT, PrakkenBJ, Seyfert-MargolisV. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol., 10, 52 (2009).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , ListaS, RissmanRAet al. Comparing biological markers of Alzheimer’s disease across blood fraction and platforms: comparing apples to oranges. Alzheimers Dement. (Amst.), 3, 27–34 (2016).
   PubMedGoogle Scholar
• O’Bryant SE , GuptaV, HenriksenKet al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research. Alzheimers Dement. (Amst.), 11(5), 549–560 (2015).
   Google Scholar
• O’Bryant SE , EdwardsM, JohnsonLet al. A blood screening test for Alzheimer’s disease. Alzheimers Dement. (Amst.), 3, 83–90 (2016).
   PubMedGoogle Scholar
• Cummings J , LeeG, MortsdorfT, RitterA, ZhongK. Alzheimer’s disease drug development pipeline: 2017. Alzheimer’ Dement. (Amst.), 3(3), 367–384 (2017).
   PubMedGoogle Scholar
• Nasrallah IM , WolkDA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J. Nucl. Med., 55(12), 2003–2011 (2014).
   PubMed Web of Science ®Google Scholar
• Zetterberg H . Cerebrospinal fluid biomarkers for Alzheimer’s disease. Curr. Opin. Psychiatry, 28(5), 402–409 (2015).
   PubMed Web of Science ®Google Scholar
• Blennow K , ZetterbergH. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J. Intern. Med., 284(6), 643–663 (2018).
   PubMed Web of Science ®Google Scholar
• Laske C , StranskyE, LeyheTet al. BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. J. Psychiatr. Res., 41(5), 387–394 (2007).
   PubMed Web of Science ®Google Scholar
• Bagyinszky E , GiauV Van, ShimK, SukK, AnSSA, KimS. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J. Neurol. Sci., 376, 242–254 (2017).
   PubMed Web of Science ®Google Scholar
• Huang L , JiaJ, LiuR. Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer’s disease and amnestic mild cognitive impairment. Neurosci. Lett., 550, 60–63 (2013).
   PubMed Web of Science ®Google Scholar
• Su F , BaiF, ZhangZ. Inflammatory cytokines and Alzheimer’s disease: a review from the perspective of genetic polymorphisms. Neurosci. Bull., 32(5), 469–480 (2016).
   PubMed Web of Science ®Google Scholar
• Rivest S . Regulation of innate immune responses in the brain. Nat. Rev. Immunol., 9(6), 429–439 (2009).
   PubMed Web of Science ®Google Scholar
• Khemka VK , GangulyA, BagchiDet al. Raised serum proinflammatory cytokines in Alzheimer’s disease with depression. Aging Dis., 5(3), 170–176 (2014).
   PubMed Web of Science ®Google Scholar
• McKhann G , DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• Heneka MT , KummerMP, LatzE. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol., 14(7), 463–477 (2014).
   PubMed Web of Science ®Google Scholar
• Hanisch UK . Proteins in microglial activation – inputs and outputs by subsets. Curr. Protein Pept. Sci., 14(1), 3–15 (2013).
   PubMed Web of Science ®Google Scholar
• Islam A , ChoudhuryME, KigamiYet al. Sustained anti-inflammatory effects of TGF-β1 on microglia/macrophages. Biochim. Biophys. Acta, 1864(3), 721–734 (2018).
   Web of Science ®Google Scholar
• Rubio-Perez JM , Morillas-RuizJM. A review: inflammatory process in Alzheimer’s disease, role of cytokines. Sci. World J., 2012, 756357 (2012).
   Web of Science ®Google Scholar
• Iadecola C , AnratherJ. The immunology of stroke: from mechanisms to translation. Nat. Med., 17(7), 796–808 (2011).
   PubMed Web of Science ®Google Scholar
• Tapia-Arancibia L , AliagaE, SilholM, ArancibiaS. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev., 59(1), 201–220 (2008).
   PubMed Web of Science ®Google Scholar
• Daynac M , PinedaJR, ChicheporticheAet al. TGFβ lengthens the G1 phase of stem cells in aged mouse brain. Stem Cells, 32(12), 3257–3265 (2014).
   PubMed Web of Science ®Google Scholar
• Piriz J , MullerA, TrejoJL, Torres-AlemanI. IGF-I and the aging mammalian brain. Exp. Gerontol., 46(2–3), 96–99 (2011).
   PubMed Web of Science ®Google Scholar
• Mateo I , LlorcaJ, InfanteJet al. Low serum VEGF levels are associated with Alzheimer’s disease. Acta Neurol. Scand., 116(1), 56–58 (2007).
   PubMed Web of Science ®Google Scholar
• Bourassa P , TremblayC, SchneiderJA, BennettDA, CalonF. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer’s disease. Acta Neuropathol., 137(5), 801–823 (2019).
   PubMed Web of Science ®Google Scholar
• Galimberti D , FenoglioC, LovatiCet al. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease. Neurobiol. Aging, 27(12), 1763–1768 (2006).
   PubMed Web of Science ®Google Scholar
• Sutinen EM , PirttiläT, AndersonG, SalminenA, OjalaJO. Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells. J. Neuroinflammation, 9, 199 (2012).
   PubMed Web of Science ®Google Scholar
• Houtman J , FreitagK, GimberN, SchmoranzerJ, HeppnerFL, JendrachM. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3. EMBO J., 38(4), pii:e99430 (2019).
   PubMed Web of Science ®Google Scholar
• Pawelec G . Age and immunity: what is ‘immunosenescence’?Exp. Gerontol., 105, 4–9 (2018).
   PubMed Web of Science ®Google Scholar
• Bateman RJ , XiongC, BenzingerTLet al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N. Engl. J. Med., 367(9), 795–804 (2012).
   PubMed Web of Science ®Google Scholar
• Ventura MT , CasciaroM, GangemiS, BuquicchioR. Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clin. Mol. Allergy, 15, 21 (2017).
   PubMedGoogle Scholar
• Rawji KS , MishraMK, MichaelsNJ, RivestS, StysPK, YongVW. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain, 139(3), 653–661 (2016).
   PubMedGoogle Scholar
• Jack CR Jr , KnopmanDS, JagustWJet al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol., 12, 207–216 (2013).
   PubMed Web of Science ®Google Scholar
• Livingston G , SommerladA, OrgetaVet al. Dementia prevention, intervention, and care. Lancet, 390(10113), 2673–2734 (2017).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr , BennettDA, BlennowKet al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement., 14, 535–562 (2018).
   PubMed Web of Science ®Google Scholar